Using the biology of chronic lymphocytic leukemia to choose treatment.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2011, Issue , 2011, Pages 104-109

  Hillmen, Peter ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BREAKPOINT CLUSTER REGION PROTEIN; PROTEIN BCL 2;

CHRONIC LYMPHATIC LEUKEMIA; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCR; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84859413533     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2011.1.104     Document Type: Review

References (0)